+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Alumis

ALMSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$10.00

0.363.73%

Pre-Market: Nov 19, 7:37 AM EDT

Alumis (ALMS) Forecast

News

Earnings Alumis (ALMS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Alumis (NASDAQ:ALMS) Stock

Alumis Stock (NASDAQ: ALMS)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, November 19, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor

Thursday, November 14, 2024

Alumis Presents Data For ESK-001 For Systemic...
Benzinga Newsdesk
Alumis shares are trading lower after HC Wain...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Al...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Alumis, ...
Benzinga Newsdesk

Wednesday, November 13, 2024

Alumis Q3 EPS $(1.73) Beats $(4.50) Estimate
Benzinga Newsdesk

Thursday, October 31, 2024

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Baird Initiates Coverage On Alumis with Outpe...
Benzinga Newsdesk

Thursday, October 17, 2024

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Vandana Singh
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Alumis shares are trading higher after HC Wai...
Benzinga Newsdesk
HC Wainwright & Co. Initiates Coverage On Alu...
Benzinga Newsdesk

Wednesday, October 09, 2024

Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
Avi Kapoor

Friday, September 27, 2024

Alumis shares are trading lower. The company ...
Benzinga Newsdesk
Alumis Presents 28-Week Data From Open Label ...
Benzinga Newsdesk

Tuesday, August 27, 2024

Samsara Biocapital LP Reports 6.9% Stake In A...
Benzinga Newsdesk

Monday, August 19, 2024

Cantor Fitzgerald Reiterates Overweight on Al...
Benzinga Newsdesk

Tuesday, August 13, 2024

Alumis Reports Q2 Net Loss Of $(56.5)M, Down ...
Benzinga Newsdesk

Wednesday, July 31, 2024

Alumis shares are trading higher. The company...
Benzinga Newsdesk

Monday, July 29, 2024

Alumis Initiates ONWARD Phase 3 Clinical Prog...
Benzinga Newsdesk

Wednesday, July 24, 2024

Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Vandana Singh
CORRECTION: Cantor Fitzgerald Initiates Cover...
Benzinga Newsdesk

Tuesday, July 23, 2024

Guggenheim Initiates Coverage On Alumis with ...
Benzinga Newsdesk
Cantor Fitzgerald Initiates Coverage On Alumi...
Benzinga Newsdesk
Leerink Partners Initiates Coverage On Alumis...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Alumis w...
Benzinga Newsdesk

Friday, June 28, 2024

Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering
Vandana Singh
Alumis IPO Price Indicating $12.25/Share On 4...
Benzinga Newsdesk
Alumis IPO Price Indicating $12/Share; IPO Pr...
Benzinga Newsdesk
Trading Halt: Halt status updated at 10:10:00...
Benzinga Newsdesk
Reported Earlier, Alumis Prices Its IPO Of 13...
Benzinga Newsdesk

Thursday, June 27, 2024

Alumis Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved